March 31, 2025 - 23:41

In a significant leadership move, OMNIA Partners has announced the appointment of Ashish Agarwal as the Executive Vice President of Technology. This strategic decision is aimed at enhancing the organization's technological capabilities and driving innovation within its operations. Agarwal brings a wealth of experience in technology management and digital transformation, having held various leadership positions in the industry.
As the Executive Vice President, Agarwal will oversee the development and implementation of technology strategies that align with OMNIA Partners' mission to deliver value to its members. His expertise will be crucial in advancing the organization’s digital initiatives and improving operational efficiency.
OMNIA Partners continues to solidify its position as a leader in group purchasing by leveraging technology to provide superior services to both public and private sector clients. Agarwal's leadership is expected to play a pivotal role in the organization's ongoing efforts to adapt to the ever-evolving technological landscape.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...